Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Penumbra Continues Push Into Peripheral Therapies

Executive Summary

Penumbra Inc. continues its push into peripheral therapies with the recent US introduction of the POD Packing Coil, designed to occlude arteries and veins in conjunction with the company's Ruby and POD (Penumbra Occlusion Device) embolization products for the treatment of peripheral vascular conditions such as aneurysms and fistulas. The POD Packing coil, which earned a 510(k) in 2015 along with a neurovascular version of the device, grew out of the platinum coil technologies used to treat brain aneurysm.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel